Silvia Wikinski

ORCID: 0000-0001-6501-2916
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neuropharmacology Research
  • Schizophrenia research and treatment
  • Neurotransmitter Receptor Influence on Behavior
  • Stress Responses and Cortisol
  • Neurogenesis and neuroplasticity mechanisms
  • Memory and Neural Mechanisms
  • Psychology Research and Bibliometrics
  • Psychological Treatments and Disorders
  • Attention Deficit Hyperactivity Disorder
  • Animal testing and alternatives
  • Treatment of Major Depression
  • Pharmacological Effects and Toxicity Studies
  • Diet and metabolism studies
  • Epilepsy research and treatment
  • Tryptophan and brain disorders
  • Health and Medical Education
  • Histone Deacetylase Inhibitors Research
  • Nerve injury and regeneration
  • Axon Guidance and Neuronal Signaling
  • Health Sciences Research and Education
  • Substance Abuse Treatment and Outcomes
  • Mental Health Research Topics
  • E-Learning and Knowledge Management
  • Veterinary Pharmacology and Anesthesia
  • Mollusks and Parasites Studies

University of Buenos Aires
2009-2024

Consejo Nacional de Investigaciones Científicas y Técnicas
2010-2024

Centro Científico Tecnológico - San Juan
2021-2024

Institute of Pharmacology
2020

Istituto di Farmacologia Traslazionale
2019

Medicina
2019

Institute of Astronomy and Space Physics
2012

Hypercortisolism is a common trait of Cushing's disease and depression. These two disorders also share hippocampal volume decrease cognitive deficits. However, experimentally induced hypercortisolism induces neuronal atrophy, which has been proposed to be the phenomenon underlying shrinkage. We hypothesized that above-mentioned atrophy due deleterious effect high concentrations glucocorticoids on cytoskeletal proteins. One or pellets (100 mg each) corticosterone were subcutaneously implanted...

10.1111/j.1460-9568.2006.05232.x article EN European Journal of Neuroscience 2006-12-01

Scarce information is available about how users experience treatment at mental health day hospitals, particularly in South America.To explore users' perspectives elements of hospital that facilitate or hinder the recovery process a facility Buenos Aires, Argentina.Semi-structured individual interviews (n = 8) and focus groups 4) were carried out with convenience sample program based on formulation, testing redevelopment propositions approach. Results analyzed through grounded theory...

10.1080/09638237.2016.1276526 article EN Journal of Mental Health 2017-01-13

Communication between patients and mental health professionals by means of messaging platforms in the interval synchronous encounters became a kind asynchronous teleconsultation (AT) whose usefulness effect on providers’ workload have not been explored. Method: Mental providers working Argentina were invited to answer survey exploring intensity AT, resulting overload.

10.53680/vertex.v35i164.547 article EN Vertex Revista Argentina de Psiquiatría 2024-07-10

Between 25% and 50% of patients suffering from treatment-resistant schizophrenia fail to achieve a clinical response with clozapine. The rapid identification treatment this subgroup represents challenge for healthcare practice.To evaluate the relationship between metabolic alterations clozapine.A multicenter, observational, case-control study was performed. Patients diagnosed treated clozapine were eligible (minimum dose 400 mg/d at least 8 weeks and/or plasma levels ⩾ 350 µg/mL). According...

10.1177/02698811231181565 article EN Journal of Psychopharmacology 2023-06-28
Coming Soon ...